Cisplatin nanocapsules (Q45274500)

11 December 2017

title

Cisplatin nanocapsules (English)

1 reference

11 December 2017

1 reference

3

Ben de Kruijff

1 reference

11 December 2017

Anton I P M de Kroon

1

1 reference

11 December 2017

Rutger W H M Staffhorst

series ordinal

2

1 reference

11 December 2017

Koert N J Burger

series ordinal

4

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

11 December 2017

published in

Methods in Enzymology

1 reference

11 December 2017

volume

391

1 reference

11 December 2017

page(s)

118-125

1 reference

Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991006-9

7 January 2021

Interaction of the anti-cancer drug cisplatin with phosphatidylserine in intact and semi-intact cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991006-9

7 January 2021

Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991006-9

7 January 2021

Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991006-9

7 January 2021

A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991006-9

7 January 2021

Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991006-9

7 January 2021

Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991006-9

7 January 2021

Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991006-9

7 January 2021

Cellular and molecular determinants of cisplatin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991006-9

7 January 2021

Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991006-9

7 January 2021

Therapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encapsulated in long-circulating pegylated stealth liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991006-9

7 January 2021

A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991006-9

7 January 2021

Preparation and stability of lipid-coated nanocapsules of cisplatin: anionic phospholipid specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991006-9

7 January 2021

10.1016/S0076-6879(05)91006-9

Identifiers

DOI

1 reference

11 December 2017

1 reference